UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Design, Synthesis, and Biological Evaluation of Analogues of the Antitumor Agent, 2-{4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy}propionic Acid (XK469)

Journal of medicinal chemistry, 2001-05, Vol.44 (11), p.1758-1776

2001

Volltextzugriff (PDF)

Preclinical antitumor activity of CI-994

Investigational new drugs, 1996, Vol.14 (4), p.349-356

1996

Volltextzugriff (PDF)

Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors

Investigational new drugs, 2005-06, Vol.23 (3), p.213-224

2005

Volltextzugriff (PDF)

Tumor Models and the Discovery and Secondary Evaluation of Solid Tumor Active Agents

International journal of pharmacognosy, 1995, Vol.33 (S1), p.102-122

1995

Volltextzugriff (PDF)

Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog

Blood, 2003-11, Vol.102 (10), p.3743-3752

2003

Volltextzugriff (PDF)

Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169

Investigational new drugs, 2003-02, Vol.21 (1), p.33-45

2003

Volltextzugriff (PDF)

CB694, a novel antimitotic with antitumor activities

International journal of cancer, 2006-02, Vol.118 (4), p.1032-1040

2006

Volltextzugriff (PDF)

Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors

Cancer chemotherapy and pharmacology, 2003-07, Vol.52 (1), p.25-33

2003

Volltextzugriff (PDF)

Preclinical antitumor activity of XK469 (NSC 656889)

Investigational new drugs, 1998, Vol.16 (4), p.287-296

1998

Volltextzugriff (PDF)

Preclinical efficacy evaluations of XK-469: Dose schedule, route and cross-resistance behavior in tumor bearing mice

Investigational new drugs, 2002-02, Vol.20 (1), p.13-22

2002

Volltextzugriff (PDF)

Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate

Investigational new drugs, 1998-01, Vol.16 (2), p.129-139

1998

Volltextzugriff (PDF)

Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human origin

Investigational new drugs, 1999-02, Vol.17 (1), p.17-27

1999

Volltextzugriff (PDF)

Discovery of cryptophycin-1 and BCN-183577 : Examples of strategies and problems in the detection of antitumor activity in mice

Investigational new drugs, 1997-01, Vol.15 (3), p.207-218

1997

Volltextzugriff (PDF)

Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice

Investigational new drugs, 1997-01, Vol.15 (2), p.99-108

1997

Volltextzugriff (PDF)

Lack of in vitro-in vivo correlation of a novel investigational anticancer agent, SH 30

Investigational new drugs, 2002-02, Vol.20 (1), p.23-33

2002

Volltextzugriff (PDF)

Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice

Cancer research (Chicago, Ill.), 1990-08, Vol.50 (16), p.4900-4905

1990

Volltextzugriff (PDF)

Preclinical antitumor efficacy of analogs of XK469: sodium-2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate

Investigational new drugs, 1998, Vol.16 (2), p.129-139

1998

Volltextzugriff (PDF)

Preclinical efficacy of thioxanthone ST271425 against transplanted solid tumors of mouse and human origin

Investigational new drugs, 1999, Vol.17 (1), p.17-27

1999

Volltextzugriff (PDF)

An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma

Archives of otolaryngology--head & neck surgery, 2005-05, Vol.131 (5), p.418

2005

Volltextzugriff (PDF)

Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice

Investigational new drugs, 1990-08, Vol.8 (3), p.253-261

1990

Volltextzugriff (PDF)

5-Fluorouracil containing combinations in murine tumor systems

Investigational new drugs, 1989-04, Vol.7 (1), p.37-49

1989

Volltextzugriff (PDF)

Activity of batracyclin (NSC-320846) against solid tumors of mice

Investigational new drugs, 1989, Vol.7 (4), p.295-306

1989

Volltextzugriff (PDF)

CARP-1 functional mimetics: a novel class of small molecule inhibitors of medulloblastoma cell growth

PloS one, 2013-06, Vol.8 (6), p.e66733

2013

Volltextzugriff (PDF)

Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study

Journal of clinical oncology, 1997-05, Vol.15 (5), p.2082-2089

1997

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaChemotherapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(24)
Medical Sciences
(24)
Antineoplastic Agents
(23)
Pharmacology. Drug Treatments
(23)
Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Mice
(18)
Animals
(17)
Oncology
(17)
Humans
(14)
Pharmacology & Pharmacy
(14)
Tumors
(12)
Female
(10)
Drug Screening Assays, Antitumor
(8)
Antineoplastic Agents - Pharmacology
(7)
Cancer
(7)
Leukemia
(7)
Antineoplastic Agents - Therapeutic Use
(6)
Male
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Design, Synthesis, and Biological Evaluation of Analogues of the Antitumor Agent, 2-{4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy}propionic Acid (XK469)

Preclinical antitumor activity of CI-994

Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors

Tumor Models and the Discovery and Secondary Evaluation of Solid Tumor Active Agents

Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog

Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169

CB694, a novel antimitotic with antitumor activities

Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors

Preclinical antitumor activity of XK469 (NSC 656889)

Preclinical efficacy evaluations of XK-469: Dose schedule, route and cross-resistance behavior in tumor bearing mice

Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate

Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human origin

Discovery of cryptophycin-1 and BCN-183577 : Examples of strategies and problems in the detection of antitumor activity in mice

Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice

Lack of in vitro-in vivo correlation of a novel investigational anticancer agent, SH 30

Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice

Preclinical antitumor efficacy of analogs of XK469: sodium-2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionate

Preclinical efficacy of thioxanthone ST271425 against transplanted solid tumors of mouse and human origin

An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma

Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice

5-Fluorouracil containing combinations in murine tumor systems

Activity of batracyclin (NSC-320846) against solid tumors of mice

CARP-1 functional mimetics: a novel class of small molecule inhibitors of medulloblastoma cell growth

A Placebo-Controlled Study of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Administered During and After Induction Treatment for De Novo Acute Myelogenous Leukemia in Elderly Patients

Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study

Aktive Filter

Suchergebnisse filtern